secwatch.observer — SEC 8-K summary
======================================

Issuer:     DiaMedica Therapeutics Inc. (DMAC)
CIK:        0001401040
Form:       8-K
Filed at:   2021-07-16T23:59:59+00:00
Accession:  0001437749-21-017038
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

DiaMedica Therapeutics elects two new directors at 2021 AGM
-----------------------------------------------------------

- Shareholders elected Amy Burroughs and Charles Semba, M.D. as directors effective immediately.
- Burroughs will serve on Audit and Nominating & Governance committees; Semba on Audit and Compensation committees.
- Four incumbent directors re-elected: Pilnik, Giuffre, Parsons, Pauls. All received >96% votes for.
- Baker Tilly US, LLP appointed as independent auditor for FY2021 with 10,734,645 votes for, none against.
- Quorum of 57.2% present; 10,748,667 shares voted out of 18,786,157 outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401040/000143774921017038/0001437749-21-017038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401040/000143774921017038/dmtp20210715_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-21-017038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer